Citation Impact
Citing Papers
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Living Radical Polymerization by the RAFT Process – A Second Update
2009 Standout
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
2012 Standout
Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity
2005
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Recent advances in the discovery and development of topoisomerase inhibitors as antitumor agents
1997
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Clinical Pharmacokinetics of Topotecan
1996
Essential elements of questionnaire design and development
2007 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Effect of pegylation on pharmaceuticals
2003 Standout
Novel 7-Alkyl Methylenedioxy-Camptothecin Derivatives Exhibit Increased Cytotoxicity and Induce Persistent Cleavable Complexes Both with Purified Mammalian Topoisomerase I and in Human Colon Carcinoma SW620 Cells
1997 StandoutNobel
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer
2010
Anthrazykline in der Krebstherapie
1997 Standout
Liposomen
1997
Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis
2016 Standout
Efficacy and safety of liposomal anthracyclines in Phase I/II clinical trials
2004
EGF–ERBB signalling: towards the systems level
2006 Standout
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Liposome: classification, preparation, and applications
2013 Standout
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Symptom Burden and Quality of Life in Survivorship
2014
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Recent advances in liposomal drug-delivery systems
1995
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
Clinical applications of the camptothecins
1998
Development of Fatigue in Cancer Survivors: A Prospective Follow-Up Study From Diagnosis Into the Year After Treatment
2012
Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis
2010
Natural Product Hybrids as New Leads for Drug Discovery
2003 Standout
Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer
2022
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Recent developments in the field of antitumour anthracyclines
2001
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Nanopharmaceuticals (part 1): products on the market
2014
Psychometric evaluation of a squestionnaire to document side‐effects of chemotherapy
1997
Liposomal drug delivery
1996
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
Liposomes as nanomedical devices
2015 Standout
Biomolecular coronas provide the biological identity of nanosized materials
2012 Standout
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
Designing dendrimers for biological applications
2005 Standout
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
2011
Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems
2011
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Synthesis of Well-Defined Alternating Copolymers by RAFT Copolymerization of N-Vinylnaphthalimide
2008
Water Soluble Inhibitors of Topoisomerase I: Quaternary Salt Derivatives of Camptothecin
1996
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Molecular Modeling Studies of the DNA−Topoisomerase I Ternary Cleavable Complex with Camptothecin
1998 StandoutNobel
Novel A-ring modified camptothecins as topoisomerase I inhibitors
1995
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Mathematics – Key Technology for the Future
2008 Standout
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
1999
DNA Topoisomerases: Structure, Function, and Mechanism
2001 Standout
Works of Patrick Cobb being referenced
Symptom trajectories during chemotherapy in outpatients with lung cancer colorectal cancer, or lymphoma
2011
Activity of DMP 840, a New Bis-naphthalimide, on Primary Human Tumor Colony-Forming Units
1994
A Phase II Trial of DaunoXome, Liposome- Encapsulated Daunorubicin, in Patients with Metastatic Adenocarcinoma of the Colon
1994
Symptom Trajectories in Posttreatment Cancer Survivors
2010
Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion
1994
Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer
2009
957 NKTR-255+cetuximab in patients with solid tumors: interim safety and efficacy results from the phase 1b dose-escalation study
2021
Unusual serpentine hyperpigmentation associated with 5-fluorouracil
1991